Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up (Q43149681)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2010
edit
Language Label Description Also known as
English
Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up
scientific article published in May 2010

    Statements

    Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up (English)
    0 references
    0 references
    387-391

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit